SI-BONE (NASDAQ:SIBN) Stock Price Down 4.5%

SI-BONE, Inc. (NASDAQ:SIBN) shares fell 4.5% during mid-day trading on Wednesday . The company traded as low as $14.97 and last traded at $14.98. 19,143 shares traded hands during trading, a decline of 95% from the average session volume of 388,195 shares. The stock had previously closed at $15.68.

Analyst Ratings Changes

A number of research firms have issued reports on SIBN. Morgan Stanley cut their price objective on shares of SI-BONE from $21.00 to $19.00 and set an “overweight” rating on the stock in a report on Tuesday, August 6th. Needham & Company LLC cut their price objective on shares of SI-BONE from $27.00 to $19.00 and set a “buy” rating on the stock in a report on Tuesday, August 6th. Finally, Truist Financial cut their price target on shares of SI-BONE from $20.00 to $18.00 and set a “buy” rating on the stock in a report on Tuesday, August 6th. Six investment analysts have rated the stock with a buy rating, According to data from MarketBeat, the stock presently has an average rating of “Buy” and a consensus target price of $23.00.

SI-BONE Stock Down 3.2 %

The stock’s fifty day moving average is $15.16 and its two-hundred day moving average is $14.99. The company has a current ratio of 9.17, a quick ratio of 8.12 and a debt-to-equity ratio of 0.22. The company has a market capitalization of $625.49 million, a PE ratio of -13.74 and a beta of 1.22.

SI-BONE (NASDAQ:SIBN) last announced its quarterly earnings data on Monday, August 5th. The company reported ($0.22) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.26) by $0.04. SI-BONE had a negative return on equity of 24.27% and a negative net margin of 27.10%. The business had revenue of $39.97 million for the quarter, compared to analysts’ expectations of $38.95 million. During the same period in the previous year, the business posted ($0.30) EPS. As a group, analysts predict that SI-BONE, Inc. will post -0.89 EPS for the current year.

Insider Activity at SI-BONE

In related news, insider Anthony J. Recupero sold 2,087 shares of the business’s stock in a transaction dated Monday, August 19th. The stock was sold at an average price of $14.17, for a total value of $29,572.79. Following the sale, the insider now directly owns 236,717 shares in the company, valued at approximately $3,354,279.89. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. In related news, insider Anthony J. Recupero sold 2,087 shares of the company’s stock in a transaction that occurred on Monday, August 19th. The shares were sold at an average price of $14.17, for a total value of $29,572.79. Following the transaction, the insider now directly owns 236,717 shares in the company, valued at $3,354,279.89. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, insider Anthony J. Recupero sold 3,905 shares of the company’s stock in a transaction that occurred on Friday, August 16th. The stock was sold at an average price of $13.84, for a total transaction of $54,045.20. Following the completion of the transaction, the insider now owns 238,804 shares in the company, valued at $3,305,047.36. The disclosure for this sale can be found here. In the last three months, insiders have sold 25,023 shares of company stock worth $347,749. Company insiders own 5.40% of the company’s stock.

Institutional Trading of SI-BONE

Hedge funds and other institutional investors have recently bought and sold shares of the company. Canada Pension Plan Investment Board purchased a new stake in shares of SI-BONE during the second quarter valued at approximately $61,000. Amalgamated Bank boosted its stake in shares of SI-BONE by 12.9% during the fourth quarter. Amalgamated Bank now owns 5,877 shares of the company’s stock valued at $123,000 after purchasing an additional 673 shares during the period. Zurcher Kantonalbank Zurich Cantonalbank boosted its stake in shares of SI-BONE by 24.7% during the second quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 10,649 shares of the company’s stock valued at $138,000 after purchasing an additional 2,108 shares during the period. Arizona State Retirement System boosted its stake in shares of SI-BONE by 9.0% during the second quarter. Arizona State Retirement System now owns 10,921 shares of the company’s stock valued at $141,000 after purchasing an additional 903 shares during the period. Finally, Deerfield Management Company L.P. Series C bought a new position in shares of SI-BONE during the second quarter valued at approximately $151,000. Hedge funds and other institutional investors own 98.11% of the company’s stock.

SI-BONE Company Profile

SI-BONE, Inc, a medical device company, that operate to solve musculoskeletal disorders of the sacropelvic anatomy in the United States and internationally. It offers proprietary minimally invasive surgical implant system to address sacroiliac joint dysfunction and fusion, adult deformity and degeneration, and pelvic trauma; and implantable bone products.